GeneCentric Diagnostics


Cancer diagnostics firm GeneCentric raises $250,000

Cancer diagnostics startup GeneCentric Diagnostics, led by former LabCorp (NYSE:LH) executive Dr. Myla Lai-Goldman, has raised $250,000, securities filings show. Besides Lai-Goldman, GeneCentric’s CEO, the filing lists only Dr. Neil Hayes, a professor at the School of Medicine at the University of North Carolina at Chapel Hill. Lai-Goldman could not be reached for comment. But […]